Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Went through six dollars with ease this morning.
Caught that too. Excellent.
I actually have a question that pertains to NTRP! Big run up these past few weeks. In the past when it was sub 4 it would do this and go back down. Lately that is not happening, levels off then continues climbing. Volume on the increase too. Most likely many reasons for this but is a big one the anticipation for upcoming data release later this year and people most importantly key people are catching on, looking around the Alz landscape no other players as far along or convincing and are buying in?
Very impressive and thoughtful response from the CEO not something most other companies would say about a competitor. I am glad I bought in and belong to it as an investor. This late summer hopefully the platform will be proven and NTRP take up the mantle as the only company treating Alzheimer's.
Thanks for this you and the others. Since my first post a while back that I was interested in what NTRP had to offer compared to other companies I have been doing a lot of my DD so as not to get burned again checking it over several times. During that time I have garnered a great deal from this board. Now that am committed to ownership of shares will make an effort to share also.
Perhaps he mixed German and English and said Große Zeit?
Perhaps if you phrased it differently: Bleed down continues with alacrity....Though that may not be sanguine enough.
My guess too. Which then puts the possibility of another reverse split on the table to maintain listing requirements.
I find it amazing that so many people are buying at these new daily 52 week lows yet the selloff and bleed down continues.
Perceptions of what is going on is subject to each individual I would say. I commend you for trying though.
Ha ha ha. Dead Carp bounce.
Sticking to my guns that this is headed sub a dollar short term. Wait and see I guess.
How is setting new lows these past several days with no end in sight something to cheer about as a long? If it goes below a dollar and stays it runs the risk of delisting, calling for a reverse split and those "cheap shares" you are now getting become very expensive. If there were short term catalyst on the horizon I would have to say your approach would be a less risky but 4th qtr 2019 before any share price moving catalyst seems extremely risky.
This is brilliant. Sheer genius to painstakingly compile this list to inspire those in despair who see their hard earn money evaporating daily and to hopefully convince them to hold on to their shares even if they go all the way to zero. Bravo, Bravo. You would have been an asset at Valley Forge during the Revolution or at the Battle of the Bulge and I mean that with all sincerity.
Moot point. I heard here that AVXL has no competitors in the search for a treatment or cure for Alzheimer's.
Your insight and knowledge is appreciated too, at least by me!!!
Thanks. I do want to get back in, not long term. Got burned last year and sold all for Tax Loss purposes. Will swing will do a lot of my own work deciding but having someone who knows the tech better helps.
Waiting for Tom123 response to my question to him about that this morning before the open.
You too.
Just hit a new 52 week low. Good chance going to get your wish!
That makes sense. We each have our own views and expectations not wrong just different. Losing over 80 percent of its value since 2016 is leading me to expect the worse here at least for the first 9 months of next year. You may very well get your price.
"I'm a Big buyer @$1.50 if it goes there."
Interesting. Would think if it goes there fast it could go below $1.00 just as easily and with no catalyst until at the very earliest 4th qtr 2019 exposing shares to devastating effects of a possible reverse split.
AT what point does this break and head for a dollar a share price. Thus causing a possible need for another reverse split to maintain listing requirements? Or is it too early to see that now? Perhaps if as you say do to no buying and continued selling if it goes to the 1.50 level without much resistance in a short period of time? Thanks.
Thanks for this. It is more grounded in reality instead of hope or speculation and will use it as a guide to get in and out with profits the next few years. Sure anything can happen but that does not mean that it will, logic is the best way to travel.
Those important individuals that matter at investment houses and analyst have no idea of the company and that is an ongoing failure of management.
Perhaps they would if the company would recruit Bastions of Industry, Finance and Philanthropy and get them on board. A concept that has worked for others.
Appears to be headed to sub 2.00 tomorrow. That ride down has been brutal.
Absolutely correct.
They are going to spend a good portion of the time discussing Safe Harbor statement.
Then go into the same bit as previous meetings, year after year about starting x number of trials (that is similar to what they always say.)
Then take two soft ball questions from analyst and none from investors and wrap it up.
The market has become all to familiar with this and with today's announcement are expecting the same old thing and reacting accordingly.
Huh? The fairly recent CMHP recommendation to allow EU to grant approval certainly is news and a current driving catalyst. Novo already bought the rights to sell in North America. The rights to sell in the EU are a hot potato and a current catalyst. This run is not just short covering.
New 52 week high. Shot right past the old one. The analysis evaluation for this stock is out of date. Person needs to update it with taking into account all the positive changes.
I hope so too. For now though am happy watching it go up in steps as we await EU approval in the next couple of months.
Caught that and that they already have run a successful trial with some paperwork to file I opened a position.
Interesting article that displays how a company gets recognition and exposure the proper way so others will take interest. Also includes said company's "unique and different" approach to Alzheimer's treatment and care from competitors.
https://www.cnbc.com/2018/11/16/facebook-cfo-david-wehner-joins-alector-board-focused-on-alzheimers.html?__source=yahoo%7Cfinance%7Cheadline%7Cstory%7C&par=yahoo&yptr=yahoo
It is grossly inaccurate and seems like the person who wrote it did it from an synopsis of the company. The company is not spending money on R and D to develop new drugs. They are looking for partners for licensing agreements with current drugs and perhaps a buyout.
"Won't know 'til we know" Seems like lowered expectations to me.
CMHP approval, next is final EU approval with in 2 months. Hopefully during the interim the company is focusing on licensing deals and or possible buyout.
NO activity and Macrilen was on the docket today to be recommended for approval by the CHMP. The result of that decision comes out tomorrow and will further propel the company. I guess not a lot of speculation here to draw the usual crowds as on some other boards.
"We should all go back to work and stop posting every 10 minutes."
If they did that some people would not get paid.
Go baby go. This is the excellent result of having a product that has approval and partnering with another company and getting a good deal on royalties.
Thanks and will look. I understand what you are saying about improvement it is just there is a big difference from studies to actually working with and trying to treat people with this or any disease. The decline is not experienced by caregivers as steady and uniform over time but comes in spurts with at times bouts of cognitive improvement that of course do not last but person eventually settles into a new average level of ability that sadly even though may be only slightly less than before it is still an unstoppable trend.
Not sure if people are aware. At least where I live. Dementia care is not a funded treatment in the DMHS sphere because it is viewed as untreatable. So once an individual receives such a diagnosis they risk losing funding and placement. Any such drug such as these early results suggest will hopefully change that mindset and allow services and funding for they to leave meaningful lives and received services they still need.